Clinical Trial

Tracking Results of Ablations to Combat AF Registry Generation 2

Study acronym: TRAC-AF
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2030-01 -> 2040-01 2026-06-30
minor Completion pushed: 2030-01 -> 2040-01 2026-06-30
Trial Details
NCT Number NCT05111015
Lead Sponsor AtriCure, Inc.
Conditions Atrial Fibrillation
Enrollment 10,000 participants
Start Date 2024-03-11
Primary Completion 2040-01 (estimated)
Study Completion 2040-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-29